Professor Ravi Gupta has been named today as one of , in recognition of his work to bring about the second-ever cure of a patient with HIV.

In 2019, the case of ‘ ̽»¨Ö±²¥London Patient’ made global headlines, as 40-year-old Adam Castillejo underwent a bone marrow transplant which both cured him of Hodgkins lymphoma, and eradicated the HIV virus from his system.

In his about Gupta for Time, Castillejo said, "Through the years, our partnership has developed and strengthened as Gupta has shared his knowledge and his enthusiasm to find a feasible cure for everyone. He has championed me and empowered me to become an ambassador of hope to millions ofÌýpeople living with HIVÌýaround the world...I’m so fortunate and humbled to know him, and to see how his dedication can conquer this disease."

As Professor of Clinical Microbiology and Wellcome Trust Senior Fellow in Clinical Science at Cambridge, Ravi’s primary research focus is on the increasing problem of drug-resistant HIV, and the potential development of alternative treatments. He is also a Professorial Fellow at Homerton College.Ìý

Since March this year, however, his attention has been on COVID-19, and increasing our understanding of the virus which has brought the world to a standstill. Early on, his work to develop rapid testing transformed the ability ofÌýhospitals to isolate infected patients. He is now in regular demand as a commentator on our evolving knowledge about how COVID-19 works and what the next stage of its impact might be.

"In the future I want to keep doing COVID-19 research alongside the HIV research," he said in June 2020. "This is partly because there’ll be plenty to do, and partly because I think there’s lots to learn that could translate to other viruses. ̽»¨Ö±²¥next pandemic may be a related virus, so we really do need to keep plugging away."



̽»¨Ö±²¥text in this work is licensed under a . Images, including our videos, are Copyright © ̽»¨Ö±²¥ of Cambridge and licensors/contributors as identified.Ìý All rights reserved. We make our image and video content available in a number of ways – as here, on our main website under its Terms and conditions, and on a range of channels including social media that permit your use and sharing of our content under their respective Terms.